Your browser doesn't support javascript.
Seroconversion Rates After the Second COVID-19 Vaccination in Patients With Systemic Light Chain (AL) amyloidosis.
Liebers, Nora; Schönland, Stefan O; Speer, Claudius; Edelmann, Dominic; Schnitzler, Paul; Kräusslich, Hans-Georg; Mueller-Tidow, Carsten; Hegenbart, Ute; Dietrich, Sascha.
  • Liebers N; Department of Medicine V, Heidelberg University Hospital, Germany.
  • Schönland SO; National Center for Tumor Diseases Heidelberg, Germany.
  • Speer C; Department of Medicine V, Heidelberg University Hospital, Germany.
  • Edelmann D; Department of Nephrology, Heidelberg University Hospital, Germany.
  • Schnitzler P; German Cancer Research Center, Division of Biostatistics, Heidelberg, Germany.
  • Kräusslich HG; Department of Infectious Diseases, Virology, Heidelberg University Hospital, Germany.
  • Mueller-Tidow C; Department of Infectious Diseases, Virology, Heidelberg University Hospital, Germany.
  • Hegenbart U; Department of Medicine V, Heidelberg University Hospital, Germany.
  • Dietrich S; National Center for Tumor Diseases Heidelberg, Germany.
Hemasphere ; 6(3): e688, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-1704301
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Journal: Hemasphere Year: 2022 Document Type: Article Affiliation country: Hs9.0000000000000688

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Journal: Hemasphere Year: 2022 Document Type: Article Affiliation country: Hs9.0000000000000688